Sleep pressure modulates single-neuron synapse number in zebrafish

Sleep is a nearly universal behaviour with unclear functions1. The synaptic homeostasis hypothesis proposes that sleep is required to renormalize the increases in synaptic number and strength that occur during wakefulness2. Some studies examining either large neuronal populations3 or small patches of dendrites4 have found evidence consistent with the synaptic homeostasis hypothesis, but whether sleep merely functions as a permissive state or actively promotes synaptic downregulation at the scale of whole neurons is unclear. Here, by repeatedly imaging all excitatory synapses on single neurons across sleep-wake states of zebrafish larvae, we show that synapses are gained during periods of wake (either spontaneous or forced) and lost during sleep in a neuron-subtype-dependent manner. However, synapse loss is greatest during sleep associated with high sleep pressure after prolonged wakefulness, and lowest in the latter half of an undisrupted night. Conversely, sleep induced pharmacologically during periods of low sleep pressure is insufficient to trigger synapse loss unless adenosine levels are boosted while noradrenergic tone is inhibited. We conclude that sleep-dependent synapse loss is regulated by sleep pressure at the level of the single neuron and that not all sleep periods are equally capable of fulfilling the functions of synaptic homeostasis.

Noradrenergic tone is not required for neuronal activity-induced rebound sleep in zebrafish

Sleep pressure builds during wakefulness, but the mechanisms underlying this homeostatic process are poorly understood. One zebrafish model suggests that sleep pressure increases as a function of global neuronal activity, such as during sleep deprivation or acute exposure to drugs that induce widespread brain activation. Given that the arousal-promoting noradrenergic system is important for maintaining heightened neuronal activity during wakefulness, we hypothesised that genetic and pharmacological reduction of noradrenergic tone during drug-induced neuronal activation would dampen subsequent rebound sleep in zebrafish larvae. During stimulant drug treatment, dampening noradrenergic tone with the α₂-adrenoceptor agonist clonidine unexpectedly enhanced subsequent rebound sleep, whereas enhancing noradrenergic signalling with a cocktail of α₁- and β-adrenoceptor agonists did not enhance rebound sleep. Similarly, CRISPR/Cas9-mediated elimination of the dopamine β-hydroxylase (dbh) gene, which encodes an enzyme required for noradrenalin synthesis, enhanced baseline sleep in larvae but did not prevent additional rebound sleep following acute induction of neuronal activity. Across all drug conditions, c-fos expression immediately after drug exposure correlated strongly with the amount of induced rebound sleep, but was inversely related to the strength of noradrenergic modulatory tone. These results are consistent with a model in which increases in neuronal activity, as reflected by brain-wide levels of c-fos induction, drive a sleep pressure signal that promotes rebound sleep independently of noradrenergic tone.

Sleep Circuits and Physiology in Non-Mammalian Systems

Research over the last 20 years has firmly established the existence of sleep states across the animal kingdom. Work in non-mammalian animal models such as nematodes, fruit flies, and zebrafish has now uncovered many evolutionarily conserved aspects of sleep physiology and regulation, including shared circuit architecture, homeostatic and circadian control elements, and principles linking sleep physiology to function. Non-mammalian sleep research is now shedding light on fundamental aspects of the genetic and neuronal circuit regulation of sleep, with direct implications for the understanding of how sleep is regulated in mammals.

Mapping oxygen concentration in the awake mouse brain

Although critical for brain function, the physiological values of cerebral oxygen concentration have remained elusive because high-resolution measurements have only been performed during anesthesia, which affects two major parameters modulating tissue oxygenation: neuronal activity and blood flow. Using measurements of capillary erythrocyte-associated transients, fluctuations of oxygen partial pressure (Po₂) associated with individual erythrocytes, to infer Po₂ in the nearby neuropil, we report the first non-invasive micron-scale mapping of cerebral Po₂ in awake, resting mice. Interstitial Po₂ has similar values in the olfactory bulb glomerular layer and the somatosensory cortex, whereas there are large capillary hematocrit and erythrocyte flux differences. Awake tissue Po₂ is about half that under isoflurane anesthesia, and within the cortex, vascular and interstitial Po₂ values display layer-specific differences which dramatically contrast with those recorded under anesthesia. Our findings emphasize the importance of measuring energy parameters non-invasively in physiological conditions to precisely quantify and model brain metabolism.

DOI:http://dx.doi.org/10.7554/eLife.12024.001

Brain cells need a constant supply of oxygen to fuel their activities. This oxygen is delivered by the flow of blood through the vessels in the brain. If the blood flow to brain tissue is cut off as happens in stroke, or if an individual stops breathing, the brain becomes deprived of oxygen and brain cells will be damaged and die. To better understand how the brain works in health and disease, scientists need to learn how much oxygen the blood must deliver to the brain tissue to adequately support the activities of brain cells.

Many studies have measured oxygen levels in the brain. However, these studies have looked only roughly and taken measurements from large areas of the brain, or they have involved animals receiving anesthesia, which can alter blood flow and oxygen use in the brain. Recently, scientists discovered that they could measure oxygen concentration at high detail in the brain of anesthetized rodents with a specialized microscope, by using molecules that emit light at a rate that depends on the local oxygen concentration.

Now, Lyons et al. have shown that this same technique can be used in mice that are awake. First, a piece of the skull was replaced with glass to create a small transparent window. Then, the animals were allowed to recover for a few weeks, and were trained to get them used to how they would be handled during the experiments. After this period, the oxygen concentrations and blood flow in different parts of the mouse brains were measured in fine detail using the microscope while the animals were awake and relaxed.

The experiments showed that oxygen levels in awake resting mice are actually lower than in anesthetized mice, and that oxygen levels differ between different parts of the mouse brain. This first detailed look at oxygen levels in the brain of awake animals will likely lead to more studies. For example, future studies may look at how quickly the brain uses oxygen under normal conditions and what happens in the brain during disease.

DOI:http://dx.doi.org/10.7554/eLife.12024.002